NCT04995185View on ClinicalTrials.gov

18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 20, 2017

Primary Completion Date

December 30, 2020

Study Completion Date

December 30, 2020

Conditions
Nasopharyngeal Carcinoma
Interventions
RADIATION

(18)F-fluoromisonidazole (FMISO)

Patients do not need to be fasted prior to intravenous injection of 370MBq ± 10% (18)F-fluoromisonidazole. Scanning will be performed two hours after the injection. Patients will be scanned with their thermoplastic shell used in routine radiotherapy treatment for 10 minutes, followed by approximately 5 minutes scan of the upper chest.

Trial Locations (2)

169608

Singapore General Hospital, Singapore

169610

National Cancer Centre, Singapore, Singapore

All Listed Sponsors
collaborator

Terry Fox Foundation

OTHER

lead

National Cancer Centre, Singapore

OTHER

NCT04995185 - 18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study | Biotech Hunter | Biotech Hunter